Evidence map›Paper›PMID 26754935›Full record

ArticleCancer research2016

Macrophage Infiltration and Alternative Activation during Wound Healing Promote MEK1-Induced Skin Carcinogenesis.

Christine Weber, Stephanie B Telerman, Andreas S Reimer, Ines Sequeira, Kifayathullah Liakath-Ali, Esther N Arwert, Fiona M Watt

Abstract read
In one paragraph

Article in Cancer research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Caspase-8-dependent autophagy regulates neutrophil infiltration in oral squamous cell carcinoma.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. IL-17: an important pathogenic factor in endometriosis.International journal of medical sciences · 2022
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Essential Oil ofMolecules (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Christine WeberCancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB12 0RE, UK.
Stephanie B TelermanKing's College London Centre for Stem Cells & Regenerative Medicine, 28 Floor, Tower Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
Andreas S Reimer *King's College London Centre for Stem Cells & Regenerative Medicine, 28 Floor, Tower Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
Ines Sequeira *King's College London Centre for Stem Cells & Regenerative Medicine, 28 Floor, Tower Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
Kifayathullah Liakath-Ali *Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB12 0RE, UK.
Esther N ArwertCancer Research UK London Research Institute, 44 Lincoln's Inn Fields, London WC2A 3LY, UK.
Fiona M WattKing's College London Centre for Stem Cells & Regenerative Medicine, 28 Floor, Tower Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.
Guy's Hospital · GBThe Francis Crick Institute · GB

Funding

2009 Fibronectin, Integrins and Related Molecules Gordon Research ConferencesR13CA137864 · NCI · GORDON RESEARCH CONFERENCES · PI WATT, FIONA MARY · 2009 to 2009
$10k
Cancer Research UK A8373Department of HealthMedical Research Council G1100073Medical Research Council MR/L022699/1NCI NIH HHS R13 CA137864Wellcome Trust 096540
6 · The paper itself

Abstract

Macrophages are essential for the progression and maintenance of many cancers, but their role during the earliest stages of tumor formation is unclear. To test this, we used a previously described transgenic mouse model of wound-induced skin tumorigenesis, in which expression of constitutively active MEK1 in differentiating epidermal cells results in chronic inflammation (InvEE mice). Upon wounding, the number of epidermal and dermal monocytes and macrophages increased in wild-type and InvEE skin, but the increase was greater, more rapid, and more sustained in InvEE skin. Macrophage ablation reduced tumor incidence. Furthermore, bioluminescent imaging in live mice to monitor macrophage flux at wound sites revealed that macrophage accumulation was predictive of tumor formation; wounds with the greatest number of macrophages at day 5 went on to develop tumors. Gene expression profiling of flow-sorted monocytes, macrophages, and T cells from InvEE and wild-type skin showed that as wound healing progressed, InvEE macrophages altered their phenotype. Throughout wound healing and after wound closure, InvEE macrophages demonstrated sustained upregulation of several markers implicated in alternative macrophage activation including arginase-1 (ARG1) and mannose receptor (CD206). Notably, inhibition of ARG1 activity significantly reduced tumor formation and epidermal proliferation in vivo, whereas addition of L-arginase to cultured keratinocytes stimulated proliferation. We conclude that macrophages play a key role in early, inflammation-mediated skin tumorigenesis, with mechanistic evidence suggesting that ARG1 secretion drives tumor development by stimulating epidermal cell proliferation. These findings highlight the importance of cancer immunotherapies aiming to polarize tumor-associated macrophages toward an antitumor phenotype.

Indexed as

Wound HealingAnimalsCarcinogenesisCell DifferentiationCell ProliferationHumansMacrophagesMAP Kinase Kinase 1MiceSkin NeoplasmsMAP Kinase Kinase 1

Identifiers

PMID26754935
PMCPMC4757739
OpenAlexW2235990650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.